Expression of proinflammatory cytokines via HIF-1α and NF-κB activation on desferrioxamine-stimulated HMC-1 cells

Biochemical and Biophysical Research Communications

Volumn 306, Issue 4, 2003, Pages 805-811

  Jeong, Hyun Ja ^a,b   Chung, Hwan Suck ^b   Lee, Bo Ra ^b   Kim, Su Jin ^a,c   Yoo, Su Jin ^d   Hong, Seung Heon ^b   Kim, Hyung Min ^a  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c Chonbuk National University   (South Korea)

^d Wonkwang University School of Medicine   (South Korea)

Author keywords

DFX; HIF 1 ; HMC 1; NF B; Proinflammatory cytokines

Indexed keywords

CYTOKINE; DEFEROXAMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; IRON; MESSENGER RNA; PROTEIN SYNTHESIS INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; TRANSCRIPTION REGULATION;

EID: 0038434290     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01073-8     Document Type: Article

References (57)

1. Semenza G.L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7:2001;345-350.
2. Minami M., Kuraishi Y., Yabuuchi K., Yamazaki A., Satoh M. Induction of interleukin-1 β mRNA in rat brain after transient forebrain ischemia. J. Neurochem. 58:1992;390-392.
3. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., Feuerstein G.Z. Tumor necrosis factor-α expression in ischemic neurons. Stroke. 25:1994;1481-1488.
4. Minami M., Kuraishi Y., Satoh M. Effects of kainic acid on messenger RNA levels of IL-1 β, IL-6, TNF alpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176:1991;593-598.
5. Karakurum M., Shreeniwas R., Chen J., Pinsky D., Yan S.D., Anderson M., Sunouchi K., Major J., Hamilton T., Kuwabara K. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest. 93:1994;1564-1570.
6. Yamashita K., Discher D.J., Hu J., Bishopric N.H., Webster K.A. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP. J. Biol. Chem. 276:2001;12645-12653.
7. Wang G.L., Semenza G.L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268:1993;21513-21518.
8. Wang G.L., Semenza G.L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood. 82:1993;3610-3615.
9. Wang G.L., Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270:1995;1230-1237.
10. Semenza G.L., Roth P.H., Fang H.M., Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:1994;23757-23763.
11. Semenza G.L., Agani F., Booth G., Forsythe J., Iyer N., Jiang B.H., Leung S., Roe R., Wiener C., Yu A. Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int. 51:1997;553-555.
12. Liu L.X., Lu H., Luo Y., Date T., Belanger A.J., Vincent K.A., Akita G.Y., Goldberg M., Cheng S.H., Gregory R.J., Jiang C. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 291:2002;908-914.
13. Beg A.A., Finco T.S., Nantermet P.V. Jr., Baldwin A.S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I κB α: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:1993;3301-3310.
14. Palombella V., Rando O., Goldberg A., Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell. 78:1994;773-785.
15. Thompson J.E., Phillips S.J., Eudjumant-Bromage H., Tempst P., Ghosh S. I κ B-β regulates the persistent response in a biphasic activation of NF-κB. Cell. 80:1995;573-582.
16. Galli S.J., Zsebo K.M., Geissler E.N. The kit ligand, stem cell factor. Adv. Immunol. 55:1994;1-96.
17. Plaut M., Pierce J.H., Watson C.J., Hanley-Hyde J., Nordan R.P., Paul W.E. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature. 339:1989;64-67.
18. Wodnar-Filipowicz A., Heusser C.H., Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature. 339:1989;150-152.
19. Bradding P., Feather I.H., Wilson S., Bardin P.G., Heusser C.H., Holgate S.T., Howarth P.H.J. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J. Immunol. 151:1993;3853-3865.
20. Van Haaster C.M., Engels W., Duijvestijn A.M., Lemmens P.J., Hornstra G., Van der Vusse G.J. Lack of evidence for a role of mast cell degranulation in acute hypoxia/reoxygenation-induced injury in the isolated rat heart. J. Mol. Cell. Cardiol. 28:1996;363-373.
21. Jeong H.J., Hong S.H., Lee D.J., Park J.H., Kim K.S., Kim H.M. Role of Ca(2+) on TNF-α and IL-6 secretion from RBL-2H3 mast cells. Cell. Signal. 14:2002;633-639.
22. Schoonbroodt S., Legrand-Poels S., Best-Belpomme M., Piette J. Activation of the NF-κB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J. 321:1997;777-785.
23. Jimenez L.A., Thompson J., Brown D.A., Rahman I., Antonicelli F., Duffin R., Drost E.M., Hay R.T., Donaldson K., MacNee W. Activation of NF-κB by PM(10) occurs via an iron-mediated mechanism in the absence of IκB degradation. Toxicol. Appl. Pharmacol. 166:2000;101-110.
24. Wenger R.H.J. Mammalian oxygen sensing, signalling, and gene regulation. J. Exp. Biol. 203:2000;1253-1263.
25. Sandau K.B., Fandrey J., Brune B. Accumulation of HIF-1α under the influence of nitric oxide. Blood. 97:2001;1009-1015.
26. Zhong H., Hanrahan C., van der Poel H., Simons J.W. Hypoxia-inducible factor 1α and 1β proteins share common signaling pathways in human prostate cancer cells. Biochem. Biophys. Res. Commun. 284:2001;352-356.
27. Alfranca A., Gutierrez M.D., Vara A., Aragones J., Vidal F., Landazuri M.O. c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol. Cell. Biol. 22:2002;12-22.
28. Charlier N., Leclere N., Felderhoff U., Heldt J., Kietzmann T., Obladen M., Gross J. Hypoxia-induced cell death and changes in hypoxia-inducible factor-1 activity in PC12 cells upon exposure to nerve growth factor. Brain Res. Mol. Brain Res. 104:2002;21-30.
29. Wanner R.M., Spielmann P., Stroka S.D., Camenisch G., Camenisch L., Scheid A., Houck D.R., Bauer C., Gassmann M., Wenger R.H. Epolones induce erythropoietin expression via hypoxia-inducible factor-1 alpha activation. Blood. 96:2000;1558-1565.
30. Stiehl D.P., Jelkmann W., Wenger R.H., Hellwig-Burgel T. Normoxic induction of the hypoxia-inducible factor 1α by insulin and interleukin-1β involves the phosphatidylinositol 3-kinase pathway. FEBS Lett. 512:2002;157-162.
31. Thornton R.D., Lane P., Borghaei R.C., Pease E.A., Caro J., Mochan E. Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem. J. 350:2000;307-312.
32. Sandau K.B., Zhou J., Kietzmann T., Brune B. Regulation of the hypoxia-inducible factor 1α by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferrioxamine and phenylarsine oxide. J. Biol. Chem. 276:2001;39805-39811.
33. Mabjeesh N.J., Willard M.T., Harris W.B., Sun H.Y., Wang R., Zhong H., Umbreit J.N., Simons J.W. Dibenzoylmethane, a natural dietary compound, induces HIF-1α and increases expression of VEGF. Biochem. Biophys. Res. Commun. 303:2003;279-286.
34. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., Poellinger L. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274:1999;6519-6525.
35. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA. 95:1998;7987-7992.
36. Salceda S., Caro J. Hypoxia-inducible factor 1α (HIF-α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272:1997;22642-22647.
37. Salceda S., Beck I., Srinivas V., Caro J. Complex role of protein phosphorylation in gene activation by hypoxia. Kidney Int. 51:1997;556-559.
38. Simakajornboon N., Gozal E., Gozal D. Developmental patterns of NF-κB activation during acute hypoxia in the caudal brainstem of the rat. Brain Res. Dev. Brain Res. 127:2001;175-183.
39. Inomata H., Ishibashi T., Murata T., Iwasaki M., Tahara A., Hata K., Yoshida A., Yoshida S., Onishi Y., Murakami M., Yamamoto M., Kubota T., Kawano Y., Sugai S., Sakamoto T., Okada T., Ishimoto S., Fujisawa K., Honda T., Sakamoto M., Shigefuji M., Tsuji I., Nishioka K., Ueno A., Nagatomi Y. Intraocular neovascularization. Nippon Ganka Gakkai Zasshi. 101:1997;906-926.
40. Matsui H., Ihara Y., Fujio Y., Kunisada K., Akira S., Kishimoto T., Yamauchi-Takihara K. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-κB and NF-IL6 in cardiac myocytes. Cardiovasc. Res. 42:1999;104-112.
41. Leeper-Woodford S.K., Detmer K. Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-κB expression. Am. J. Physiol. 276:1999;909-916.
42. Lee T.H., Avraham H., Lee S.H., Avraham S. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J. Biol. Chem. 277:2002;10445-10451.
43. Haddad J.J., Olver R.E., Land S.C. Antioxidant/pro-oxidant equilibrium regulates HIF-α and NF-κB redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J. Biol. Chem. 275:2000;21130-21139.
44. Stanimirovic D., Zhang W., Howlett C., Lemieux P., Smith C. Inflammatory gene transcription in human astrocytes exposed to hypoxia: roles of the nuclear factor-κB and autocrine stimulation. J. Neuroimmunol. 119:2001;365-376.
45. Benyo D.F., Smarason A., Redman C.W., Sims C., Conrad K.P.J. Expression of inflammatory cytokines in placentas from women with preeclampsia. J. Clin. Endocrinol. Metab. 86:2001;2505-2512.
46. Pearlstein D.P., Ali M.H., Mungai P.T., Hynes K.L., Gewertz B.L., Schumacker P.T. Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia. Arterioscler. Thromb. Vasc. Biol. 22:2002;566-573.
47. Kim H.M., Shin H.Y., Jeong H.J., An H.J., Kim N.S., Chae H.J., Kim H.R., Song H.J., Kim K.Y., Baek S.H., Cho K.H., Moon B.S., Lee Y.M. Reduced IL-2 but elevated IL-4, IL-6, and IgE serum levels in patients with cerebral infarction during the acute stage. J. Mol. Neurosci. 14:2000;191-196.
48. Pudil R., Krejsek J., Pidrman V., Gregor J., Tichy M., Bures J. Inflammatory response to acute myocardial infarction complicated by cardiogenic shock. Acta. Medica. (Hradec Kralove). 44:2001;149-151.
49. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 12:2001;375-391.
50. Matsumoto T., Ikeda K., Mukaida N., Harada A., Matsumoto Y., Yamashita J., atsushima K. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab. Invest. 77:1997;119-125.
51. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc. Res. 53:2002;31-47.
52. Baumgartner R.A., Yamada K., Deramo V.A., Beaven M.A. Secretion of TNF from a rat mast cell line is a brefeldin A-sensitive and a calcium/protein kinase C-regulated process. J. Immunol. 153:1994;2609-2617.
53. Santamaria B.L.F., Moser R., Perez Soler M.T., Picker L.J., Blaser K., Hauser C. Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). J. Immunol. 154:1995;1543-1550.
54. S.B. Seo, H.J. Jeong, H.S. Chung, K. Toshio, J.D. Lee, H.M. Kim, Inhibitory effect of high molecular weight water-soluble chitosan on hypoxia-induced inflammatory cytokine production, Biol. Pharm. Bull. 26 (2003) 717-721.
55. Steiner D.R., Gonzalez N.C., Wood J.G. Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J. Appl. Physiol. 94:2003;325-334.
56. Valent P., Baghestanian M., Bankl H.C., Sillaber C., Sperr W.R., Wojta J., Binder B.R., Lechner K. New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells. Thromb. Haemost. 87:2002;786-790.
57. Francuz T. Mast cells and atherosclerosis. Przegl. Lek. 58:2001;1004-1008.